Clinical Trials Directory

Trials / Unknown

UnknownNCT01817101

Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.

Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether an omega-3 fatty acid supplementation is effective in the prevention of progressive cognitive decline in elderly people aged 75 years or older.

Detailed description

Participants are residents at three nursing homes in Pamplona (Spain). We assumed that 20% of elderly people have a cognitive decline and we estimated a 5% of cognitive decline in the intervention group. Sample size estimated was 85 participants for each arm, assuming two groups with an alpha of 0.05, 80% power and accounting for 10% of participants lost to follow-up. Repeated measures ANOVA, Cox regression and multiple linear regression analysis will be used for the statistical analysis of data.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3 fatty acid supplementationGelatine capsule, 1 at each meals (3 per day) during one year

Timeline

Start date
2012-01-01
Primary completion
2015-10-01
Completion
2015-12-01
First posted
2013-03-22
Last updated
2015-07-17

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01817101. Inclusion in this directory is not an endorsement.